Discontinued — last reported Q3 '24
Zimmer Biomet Holdings Corporate Items — Operating Income decreased by 2.3% to -$421.80M in Q3 2024 compared to the prior quarter. Year-over-year, this metric declined by 6.5%, from -$396.10M to -$421.80M. This is a positive signal — lower values indicate better performance for this metric.
A widening loss suggests rising administrative or corporate overhead, while a narrowing loss indicates successful cost-containment initiatives or improved operational efficiency at the corporate level.
This metric represents the net operating costs incurred at the corporate level that are not allocated to specific busine...
Most multinational corporations report a similar unallocated corporate loss, which investors monitor to assess the efficiency of the company's central management structure.
zbh_segment_corporate_items_operating_income_loss| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$268.80M | -$240.60M | -$444.90M | -$270.60M | -$274.50M | -$244.90M | -$325.40M | -$387.90M | -$399.40M | -$396.10M | -$477.60M | -$412.40M | -$421.80M |
| QoQ Change | — | +10.5% | -84.9% | +39.2% | -1.4% | +10.8% | -32.9% | -19.2% | -3.0% | +0.8% | -20.6% | +13.7% | -2.3% |
| YoY Change | — | — | — | — | -2.1% | -1.8% | +26.9% | -43.3% | -45.5% | -61.7% | -23.1% | -3.3% | -6.5% |